Blog
About

3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The premise of inhibiting autophagy to overcome resistance to chemotherapy has been investigated in 5 clinical phase I trials combining hydroxychloroquine with vorinostat, temsirolimus, temozolomide, or bortezomib. These studies have provided a number of insights relating to the tolerability of the combination treatments. In addition, these studies should provide guidance in the planning and design of future trials to directly determine whether the strategy of autophagy inhibition could prove useful in the treatment of various malignancies.

          Related collections

          Author and article information

          Journal
          Autophagy
          Autophagy
          1554-8635
          1554-8627
          Aug 2014
          : 10
          : 8
          Affiliations
          [1 ] Division of Hematology and Oncology; Virginia Commonwealth University; Massey Cancer Center; Richmond, VA USA.
          [2 ] Department of Pharmacology, Toxicology and Medicine; Virginia Commonwealth University; Massey Cancer Center; Richmond, VA USA.
          Article
          29428
          10.4161/auto.29428
          4203528
          24991829

          Comments

          Comment on this article